IP Library Granted Patent US 7,211,062
Granted Patent B2
US 7,211,062 · App. 10/767,359 · Granted May 1, 2007

Solid solution perforator for drug delivery and other applications

Assignee: TheraJect, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,211,062
App. No.
10/767,359
Granted
May 1, 2007
Kind
B2
Abstract

A solid drug perforator (SSP) system and an associated drug reservoir are provided for delivering theraputic, prophylactic and/or cosmetic compounds, for nutrient delivery and for drug targeting. For drug delivery, the SSP system includes an active drug ingredient and a matrix of perforator material that biodegrades or dissolves quickly upon contact with a patient's body. The SSP system provides a skin barrier perforator and a controller for prompt initiation and cut-off of drug delivery. In a preferred method of transdermal drug delivery, an SSP system containing a selected drug penetrates into an epidermis or dermis, and the drug is promptly released from the (dissolving) SSP system perforator. An additional drug is optionally delivered from a patch reservoir through skin pores created by insertion of the perforator. Formulation and fabrication procedures for the SSP and associated reservoir are also provided. An SSP system can be fabricated with variety of shapes and dimensions.

Claims (21)

1. A system for delivering a substance into tissue comprising:

a patch including

a basal layer having a first side and a second side, and

a plurality of micro-perforators projecting from the first side of the basal layer and formed from a solid matrix material without channels or passageways that are dissolved by a solvent in the tissue to form channels for delivering a substance into the tissue by diffusion, wherein the matrix material comprises a polymer or a carbohydrate derivative; and

a reservoir, including the solvent that dissolves the solid matrix material upon contact with the solvent over a time interval of between a few tens of seconds and a few hours after the micro-perforators have been inserted into a patient's body, wherein the reservoir can be attached to the second side of the basal layer.

2. The system of claim 1 wherein the matrix material comprises the substance.

3. The system of claim 1 wherein the reservoir further includes the substance.

4. The system of claim 3 wherein the matrix material comprises a second substance.

5. The system of claim 1 wherein the substance is a drug.

6. The system of claim 1 wherein the matrix material comprises a polymer.

7. The system of claim 1 wherein the matrix material comprises a carbohydrate derivative.

8. The system of claim 1 wherein the matrix material is water-soluble.

9. The system of claim 1 wherein the reservoir is integrally attached to the second side of the basal layer.

10. A method for delivering a substance into tissue comprising:

forming a plurality of channels into the tissue by

affixing a patch including a basal layer having a first side and a second side, and a plurality of micro-perforators projecting from the first side of the basal layer and formed of a solid matrix material without channels or passageways into the tissue, wherein the matrix material comprises a polymer or a carbohydrate derivative, and

dissolving the solid matrix material to form the plurality of channels, wherein the matrix material dissolves over a time interval of between a few tens of seconds and a few hours after the micro-perforators have been inserted into a patient's body, wherein dissolving the matrix material comprises attaching to the patch a reservoir of a solvent effective to dissolve the matrix material upon contact with the solvent, and delivering the solvent from the reservoir to the micro-perforators; and

delivering the substance through the plurality of channels by diffusion.

11. The method of claim 10 wherein dissolving the matrix material is effective to deliver a second substance into the tissue.

12. The method of claim 10 wherein the method further comprises removing the basal layer from the tissue after the micro-perforators have dissolved.

13. The method of claim 10 that further comprises activating a perforation activation mechanism that is effective to insert the plurality of micro-perforators to a predetermined distance into the tissue.

Assignments (3)
LICENSE Recorded Jun 22, 2012
From: THERAJECT, INC.
To: B2Y, INC.
Reel/Frame 028427/0796 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2005
From: KWON, SUNG-YUN
To: THERAJECT, INC.
Reel/Frame 016325/0625 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2004
From: KWON, SUNG-YUN
To: THERAJECT, INC.
Reel/Frame 014946/0589 →
Continuity (2)
Continuation 1017974900 · Jun 25, 2002
Related Publication 20040199103A1 · Oct 7, 2004